Discovery of Novel 5α-Reductase Type II Inhibitors by Pharmacophore Modelling, Virtual Screening, Molecular Docking and Molecular Dynamics Simulations

    January 2014 in “ Molecular Simulation ”
    Jhih-Lun Wang, Hsuan‐Liang Liu, Zheng-Li Zhou, Wei-Hsi Chen, Yih Ho
    TLDR A new compound may treat benign prostatic hyperplasia better than finasteride.
    The study focused on discovering novel inhibitors for 5α-reductase type II, an enzyme linked to conditions like androgenetic alopecia. Researchers employed pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulations to identify potential inhibitors. These computational techniques allowed the identification of compounds that could effectively bind to and inhibit the enzyme, suggesting a promising direction for developing new treatments for hair loss and related conditions. The study highlighted the potential of these novel inhibitors in therapeutic applications, although further experimental validation was necessary to confirm their efficacy and safety.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results

    Related Community Posts Join

    6 / 181 results

      community Why does it seem everyone favors finasteride over dutasteride?

      in Female  62 upvotes 1 year ago
      The conversation discusses preferences for hair loss treatments, specifically finasteride over dutasteride. Users share personal experiences, cost considerations, FDA approval status, and potential side effects, with some switching between treatments to find what works best for them.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      by nkrata in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Experiences with Annurmets Hair?

      in Product  6 upvotes 4 years ago
      User asks about Annurmets Hair product, high in Procyanidin B2 for hair regrowth. Product is expensive and ordered from Italy.

      community Dutasteride Literally Saves Your Hair

      in Finasteride/Dutasteride  101 upvotes 1 year ago
      Dutasteride significantly reduces scalp DHT levels and can save hair, though shedding is part of the process. Some users report success with dutasteride, while others struggle despite using it along with finasteride and oral minoxidil.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 9 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

    Similar Research

    6 / 1000+ results